Gilead Sciences (NASDAQ:GILD – Get Free Report) had its price target hoisted by equities researchers at Morgan Stanley from $123.00 to $130.00 in a research note issued to investors on ...

Afya (NASDAQ:AFYA – Get Free Report) was downgraded by investment analysts at Morgan Stanley from an “equal weight” rating to ...

Intel (NASDAQ:INTC) just sent its stock soaring after-hours – up more than 10% – all thanks to a big leadership shake-up. The company announced ...

Thursday closed down -1.39%, the Dow Jones Industrials Index ($DOWI) (DIA) closed down -1.30%, and the Nasdaq 100 Index ...

NEW YORK — Wall Street’s sell-off hit a new low Thursday after President Donald Trump’s escalating trade war dragged the S&P ...

Shares of Apple Inc. (NASDAQ:AAPL – Get Free Report) dropped 2.5% on Wednesday after Morgan Stanley lowered their price ...

ArcBest (NASDAQ:ARCB – Get Free Report)‘s stock had its “overweight” rating reaffirmed by Stephens in a research report ...

Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) had its price objective boosted by stock analysts at JPMorgan Chase & Co. from $272.00 to $280.00 in a report released on Tuesday,Benzinga ...

ArcBest (NASDAQ:ARCB – Get Free Report) had its price target decreased by analysts at Citigroup from $103.00 to $83.00 in a ...

Opal Wealth Advisors LLC grew its stake in NVIDIA Co. (NASDAQ:NVDA – Free Report) by 0.8% during the fourth quarter, ...

Shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) have been assigned a consensus recommendation of “Hold” from ...